Advertisement
News
Advertisement

New BSX chief plans to turn company around

Fri, 11/02/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Boston Scientific CEO Michael Mahoney plans to lead the Natick medical device maker’s growth in 2013 through innovation and by integrating its recent acquisitions of BridgePoint Medical Inc. and Rhythmia Medical Inc.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading